HomeCompareSYK vs MA

SYK vs MA: Dividend Comparison 2026

SYK yields 1.04% · MA yields 0.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MA wins by $453.9K in total portfolio value· pulled ahead in Year 3
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
MA
MA
● Live price
0.64%
Share price
$494.00
Annual div
$3.15
5Y div CAGR
91.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$497.2K
Annual income
$341,049.48
Full MA calculator →

Portfolio growth — SYK vs MA

📍 MA pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKMA
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + MA cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
MA pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
MA
Annual income on $10K today (after 15% tax)
$54.20/yr
After 10yr DRIP, annual income (after tax)
$289,892.06/yr
At 15% tax rate, MA beats the other by $282,851.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + MA for your $10,000?

SYK: 50%MA: 50%
100% MA50/50100% SYK
Portfolio after 10yr
$270.3K
Annual income
$174,666.23/yr
Blended yield
64.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MA right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
MA
Analyst Ratings
1
Strong
51
Buy
12
Hold
Consensus: Buy
Price Target
$667.33
+35.1% upside vs current
Range: $610.00 — $739.00
Altman Z
9.7
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
MA buys
8
PoliticianChamberTickerTypeAmountDate
Sheldon Whitehouse🏛 Senate$MA▼ Sell$1,001 - $15,0002026-02-23
Markwayne Mullin🏛 Senate$MA▲ Buy$50,001 - $100,0002025-12-29
Markwayne Mullin🏛 Senate$MA▲ Buy$50,001 - $100,0002025-12-29
Michael McCaul🏢 House$MA▼ Sell$1,001 - $15,0002025-10-27
Gilbert Cisneros🏢 House$MA▲ Buy$1,001 - $15,0002025-10-17
Val Hoyle🏢 House$MA▼ Sell$1,001 - $15,0002025-09-23
Ro Khanna🏢 House$MA▲ Buy$1,000 - $15,0002025-08-04
Lisa McClain🏢 House$MA▼ Sell$1,001 - $15,0002025-06-24
Lisa McClain🏢 House$MA▲ Buy$1,001 - $15,0002025-06-17
Michael McCaul🏢 House$MA▼ Sell$15,001 - $50,0002025-06-16
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKMA
Forward yield1.04%0.64%
Annual dividend / share$3.40$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%91.8%
Portfolio after 10y$43.3K$497.2K
Annual income after 10y$8,282.98$341,049.48
Total dividends collected$21.0K$463.2K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusBuyBuy
Analyst price target$428.67$667.33

Year-by-year: SYK vs MA ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrMA PortfolioMA Income/yrGap
1$10,852$152.43$10,822$122.30+$30.00SYK
2$11,838$226.03$11,817$237.26+$21.00SYK
3← crossover$13,004$336.89$13,109$464.38$105.00MA
4$14,420$505.63$14,950$923.39$530.00MA
5$16,195$766.09$17,884$1,887.66$1.7KMA
6$18,504$1,175.64$23,183$4,047.78$4.7KMA
7$21,635$1,835.40$34,212$9,405.89$12.6KMA
8$26,082$2,932.10$61,488$24,880.97$35.4KMA
9$32,737$4,829.68$145,949$80,157.01$113.2KMA
10$43,312$8,282.98$497,215$341,049.48$453.9KMA

SYK vs MA: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

MAFinancials

Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally. It facilitates the processing of payment transactions, including authorization, clearing, and settlement, as well as delivers other payment-related products and services. The company offers integrated products and value-added services for account holders, merchants, financial institutions, businesses, governments, and other organizations, such as programs that enable issuers to provide consumers with credits to defer payments; prepaid programs and management services; commercial credit and debit payment products and solutions; and payment products and solutions that allow its customers to access funds in deposit and other accounts. It also provides value-added products and services comprising cyber and intelligence solutions for parties to transact, as well as proprietary insights, drawing on principled use of consumer, and merchant data services. In addition, the company offers analytics, test and learn, consulting, managed services, loyalty, processing, and payment gateway solutions for e-commerce merchants. Further, it provides open banking and digital identity platforms services. The company offers payment solutions and services under the MasterCard, Maestro, and Cirrus. Mastercard Incorporated was founded in 1966 and is headquartered in Purchase, New York.

Full MA Calculator →
📬

Get this SYK vs MA comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.